Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer's disease.

Caterina MottaFrancesco Di LorenzoViviana PonzoMaria Concetta PellicciariSonia BonnìSilvia PicazioNicola Biagio MercuriCarlo CaltagironeAlessandro MartoranaGiacomo Koch

Published in: Journal of neurology, neurosurgery, and psychiatry (2018)

TMS-based assessment of LTP-like cortical plasticity could be a viable biomarker to assess synaptic impairment and predict subsequent cognitive decline progression in patients with ADs.

Keyphrases

cognitive decline
transcranial magnetic stimulation
high frequency
mild cognitive impairment
prefrontal cortex